From Prescription to Patient: Navigating Barriers to HCV Treatment Initiation


  • Describe the financial impact of HCV treatment
  • Identify current restrictions to HCV treatment common among third party payers
  • Illustrate successful navigation through the prior authorization and appeal process
  • Review criteria and options for patient assistance programs (PAP)


Autumn Bagwell PharmD BCPS

Browse more